Simple Non-Invasive Test Predicts Heart Risk In Postmenopausal Women
Main Category: Cardiovascular / CardiologyAlso Included In: Women's Health / Gynecology
Article Date: 18 Apr 2008 - 2:00 PST
| Patient / Public: | ![]() |
4.67 (3 votes) |
| Healthcare Prof: | ![]() |
Endothelial dysfunction is a disordered function of very small coronary vessels that cannot be seen by angiograms done during cardiac catheterization. The impairment of endothelial function is the primary etiology implicated in the origin and development of atherosclerosis. In a prospective study of 2264 post-menopausal women, endothelial function was measured by utilizing the noninvasive measurement of the brachial artery flow characteristics. When added to age and other conventional cardiovascular risk factors (smoking habits, presence of hypercholesterolemia, history of diabetes, hypertension), endothelial dysfunction contributed significantly to predicting heart risk. {Journal of the American College of Cardiology, V. 51, No. 10 (11 March 2008), pp. 997-1002}. L-arginine, an amino acid, promotes healthy blood vessels by its antioxidant properties and reducing endothelial dysfunction.(a)
Advanced Cardiac Life Sciences, LLC (ACLS), is pleased to announce the continued success of CardioVance® and CardioVance.com, offering educational resources and evidence-based nutritional supplementation for women's heart health. CardioVance® is cardiologist-formulated for women concerned about heart health. CardioVance's development stems from increasing consumer demand to optimize heart health naturally while at the same time applying scientific rigor to the development of nutritional supplementation.
CardioVance® helps women to improve endothelial dysfunction, maintain normal blood pressure and cholesterol, and promote a healthy cardiovascular system by incorporating Omega-3 Fish Oils, CoEnzyme Q10, L-arginine, Calcium and Vitamin D, and a powerful multivitamin into a convenient daily nutrition pack.(a)CardioVance.com advances the fight against women's heart disease, empowers women through educational resources, and incorporates evidence-based science into nutritional supplementation.
For additional information or details concerning marketing CardioVance®, visit http://www.cardiovance.com. CardioVance is a Registered Trademark of Advanced Cardiac Life Sciences, LLC.
(a)These statements have not been reviewed by the Food and Drug Administration. This product should be taken as part of a healthy lifestyle and is not intended to diagnose, treat, cure, or prevent any disease.
CardioVance
Visit our cardiovascular / cardiology section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/104460.php>
APA
http://www.medicalnewstoday.com/releases/104460.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





